Modus Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Modus Advisors's PFE Position: Q1 2026 in Review
Modus Advisors sold out of Pfizer (PFE) in Q1 2026, closing a stake of 1,800 shares — an estimated $44.8K sold.
Modus Advisors first reported a position in PFE in Q4 2019 and held it in 19 quarters. The position peaked at $2.81M in Q4 2021. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Modus Advisors reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Modus Advisors sold 1,800 Pfizer shares in Q1 2026, an estimated $44.8K.
- Modus Advisors first reported a position in Pfizer in Q4 2019 and held it in 19 quarters.
- Modus Advisors's Pfizer position peaked at $2.81M in Q4 2021.
- 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Modus Advisors's 13F filing for Q1 2026, filed 4 May 2026.